Literature DB >> 15201164

"Energenetics" of heart failure.

Marc van Bilsen1.   

Abstract

It has been postulated that the failing heart suffers from chronic energy starvation, and that the derangements in cardiac energy production contribute to the inevitable transition from compensated hypertrophy to decompensated heart failure. Although the existence of metabolic alterations is hardly disputed anymore, the molecular mechanisms driving this "metabolic remodeling" process and its significance for the development of cardiac failure are still open to discussion. Next to changes in mitochondrial function, the hypertrophied heart is characterized by a marked change in substrate preference away from fatty acids toward glucose. Several lines of evidence suggest that these metabolic adaptations are brought about, at least in part, by alterations in the rate of transcription of genes encoding for proteins involved in substrate transport and metabolism. Here, we present an overview of the principal metabolic changes and discuss the various mechanisms that are likely to play a role, with special emphasis on gene regulatory mechanisms. In addition, the significance of these changes for the etiology of heart failure is discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15201164     DOI: 10.1196/annals.1302.020

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha.

Authors:  Zoltan Arany; Mikhail Novikov; Sherry Chin; Yanhong Ma; Anthony Rosenzweig; Bruce M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-14       Impact factor: 11.205

2.  Elevated expression of the metabolic regulator receptor-interacting protein 140 results in cardiac hypertrophy and impaired cardiac function.

Authors:  Asmaà Fritah; Jennifer H Steel; Donna Nichol; Nadeene Parker; Sharron Williams; Anthony Price; Leena Strauss; Timothy A Ryder; Margaret A Mobberley; Matti Poutanen; Malcolm Parker; Roger White
Journal:  Cardiovasc Res       Date:  2010-01-18       Impact factor: 10.787

3.  High-resolution longitudinal MRI of the transition to heart failure.

Authors:  Peter N Costandi; Andrew D McCulloch; Jeffrey H Omens; Lawrence R Frank
Journal:  Magn Reson Med       Date:  2007-04       Impact factor: 4.668

Review 4.  PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation.

Authors:  Ching-Feng Cheng; Hui-Chen Ku; Heng Lin
Journal:  Int J Mol Sci       Date:  2018-11-02       Impact factor: 5.923

5.  Cardiac function evaluation for a novel one-step detoxification product of Aconiti Lateralis Radix Praeparata.

Authors:  Ya-Nan He; Ding-Kun Zhang; Jun-Zhi Lin; Xue Han; Ya-Ming Zhang; Hai-Zhu Zhang; Jin Pei; Ming Yang; Jia-Bo Wang
Journal:  Chin Med       Date:  2018-12-17       Impact factor: 5.455

Review 6.  Mitochondrial Bioenergetics and Dynamism in the Failing Heart.

Authors:  Giampaolo Morciano; Veronica Angela Maria Vitto; Esmaa Bouhamida; Carlotta Giorgi; Paolo Pinton
Journal:  Life (Basel)       Date:  2021-05-12

7.  The PPARalpha-PGC-1alpha Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium.

Authors:  Jennifer G Duncan; Brian N Finck
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.